Setting the standard in DNA testing
The power of microarray testing of multiple pathogens with
best-in-class sensitivity and specificity.
best-in-class sensitivity and specificity.
![DetectX](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2019/11/DetectX.png?time=1725739791)
![QuantX](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2019/11/QuantX.png?time=1725739791)
CERTAINTY THAT CREATES RELATIONSHIPS LABS CAN COUNT ON.
Labs don’t need an assay supplier. They need a partner. At PathogenDx, we care deeply about continually improving our testing solutions and supporting laboratories to increase efficiency, reduce costs, and optimize their business. Learn about our science and commitment below.
HOW WE DELIVER RESULTS IN JUST 6 HOURS.
PathogenDx: Definitive, Quantified DNA-based Test Results in 6 Hours or Less.
![Timeline](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2019/11/Timeline.png?time=1725739791)
Today, PathogenDx harnesses the power of DNA science to deliver accurate, ultra-rapid pathogen detection, without the need for DNA purification, quantitation, or quality analysis. Our new technology reduces as many as 20 steps versus current qPCR methods, delivering results in as little as six hours while nearly eliminating false positives and false negatives.
A century of advancement in a simple kit.
IT’S FAST
No longer is extraction and purification required for DNA based testing! Our process requires less laboratory time and space, and returns definitive results in 6 hours, at a fraction of the test costs.
It’s Scalable
With PathogenDx, multiplexes are utilized to identify multiple pathogens in a single, simple test and up to 96 samples in a single day.
It’s Replicable
Our simple, solid-state microarray technology provides testing data in triplicate delivering consistent, replicable results even in microbial organisms that are difficult to incubate plated cultures.
PERFORMANCE UNMATCHED
HERE ARE JUST A FEW OF OUR STRATEGIC TESTING LABORATORY PARTNERS THAT HAVE MULTIPLE LAB LOCATIONS
![advancedGeneticsLab](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/04/advancedGeneticsLab.jpg?time=1725739791)
![MedLabs](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/04/MedLabs-1.jpg?time=1725739791)
![nwls](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/04/nwls.jpg?time=1725739791)
![TestingMatters](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/04/TestingMatters.jpg?time=1725739791)
![Revolution](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/04/Revolution.jpg?time=1725739791)
![CaPublicHealth](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/03/CaPublicHealth.jpg?time=1725739791)
![ClinicalLabConsulting](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/01/ClinicalLabConsulting.jpg?time=1725739791)
![AmericanClinicalSloutions](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/03/AmericanClinicalSloutions.jpg?time=1725739791)
“To ensure consistent safety standards that keep businesses and people safe, we’ve expanded the capability of the first-ever DNA-based microarray platform for pathogen testing.”
-Milan Patel
Co-Founder & CEO
Co-Founder & CEO
![healthcare_labB](https://g5u082.a2cdn1.secureserver.net/wp-content/uploads/2020/04/healthcare_labB.jpg?time=1725739791)